Acute metformin intoxication: 2012 experience of Emergency Departement of Lodi, Italy

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 10, 2014, Pages 1489-1497

  Acquistapace, Giulia ^a,b   Rossi, Marco ^a,c   Garbi, Mara ^a   Cosci, Pablo ^b   Canetta, Ciro ^c   Manelli, Anna ^c   Ricevuti, Giovanni ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Azienda Ospedaliera della Provincia di Lodi   (Italy)

^c Azienda Ospedaliera di Melegnano   (Italy)

Author keywords

Lactic acidosis; Levofloxacin; Metformin intoxication; Myocardial infarction; Renal failure

Indexed keywords

ANAGRELIDE; BICARBONATE; BISOPROLOL; DELAPRIL; GLICLAZIDE; HYDROCHLOROTHIAZIDE PLUS OLMESARTAN; INDAPAMIDE; LEVOFLOXACIN; METFORMIN; REPAGLINIDE; SIMVASTATIN; TROPONIN; ANTIDIABETIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; AMPUTATION; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; COLITIS; COLONOSCOPY; CONTINUOUS HEMOFILTRATION; DEATH; DIARRHEA; DRUG BLOOD LEVEL; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEMODYNAMICS; HUMAN; HYPERLACTATEMIA; HYPOGLYCEMIA; HYPOTENSION; INTENSIVE CARE UNIT; ITALY; KIDNEY FUNCTION; MALE; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOMYELITIS; OXYGEN SATURATION; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; SEPSIS; TACHYCARDIA; URINARY TRACT INFECTION; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; EMERGENCY HEALTH SERVICE; LACTIC ACIDOSIS; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ACIDOSIS, LACTIC; AGED; DIABETES MELLITUS, TYPE 2; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEMODYNAMICS; HUMANS; HYPOGLYCEMIC AGENTS; ITALY; MALE; METFORMIN; MIDDLE AGED; RENAL DIALYSIS;

EID: 84921367632     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0208     Document Type: Article

References (37)

1. Matthews SJ. Focus on metformina new biguanide antihypertensive agent. Formulary 1995;30:383-7.
2. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin [letter]. N Engl J Med 1998;338:265-6.
3. Viollet B, Foretz M. Revisiting the mechanisms of metformin action in the liver. Ann Endocrinol 2013;74:123-9.
4. Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab 2006;291:E182-9.
5. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-9.
6. Fantus IG, Brosseau R. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. J Clin Endocrinol Metab 1986;63:898-905.
7. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002;51:2074-81.
8. Viollet B, Guigass B, Sanz Garcia N, Leclerc J, Forets M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci 2012;122:253-70.
9. Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011;50:81-98.
10. Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009;37:2191-6.
11. Berger W. Incidence of severe side effects during therapy with sulfonylureas and biguanides. Horm Metab Res 1985;15(Suppl):111-5.
12. Wiholm BE, Myrhed M. Metformin-associated lactic acidosis in Sweden. 1977-1991. Eur J Clin Pharmacol 1993;44:589-91.
13. Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998;21:1659-63.
14. Stacpoole PW. Metformin and lactic acidosis. Guilt by association? Diabetes Care 1998;21:1587-8.
15. Kruse JA. Metformin-associated lactic acidosis. J Emerg Med 2001;20:267-72.
16. Luft F. Lactic acidosis update for clinical care condition. J Am Soc Nephrol 2001;12:S15-9.
17. Luft D, Deichsel G, Schmülling RM, Stein W, Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol 1983;80:484-9.
18. Moffat AC, Osselton MD, Widdop B, editors. Clarke's analysis of drugs and poisons, III ed. London: Pharmaceutical Press, 2004.
19. Uges D, Steentoft A, Winek C. Society of toxicological and forensic chemistry. TIAFT (The International Association of Forensic Toxicologists) References blood level list of therapeutic and toxic substances". Available from: http://www.gtfch.org/ems/ images/stories/Uptaded TIAFTlist-202005.pdf Accessed on July 3, 2012.
20. Repetto MR, Repetto M. Tabla de concentraciones de xenobioticos en fluidos humanos como referencia para el diagnostico toxicologico. Available from: http://www.busca-tox.com. Accessed on July 3, 2012.
21. Nisse P, Mathieu-Nolf M, Deveaux M, Forceville X, Combes A. A fatal case of metformin poisoning. J Toxicol Clin Toxicol 2003;41:1037-8.
22. Lacher M, Hermanns-Clausen M, Haeffner K, Brandis M, Pohl M. Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr 2005;164:362-5.
23. Lalau JD, Mourhlhon C, Bergeret A, Lacroix C. Consequences of metformin intoxication. Diabetes Care 1998;21:2036-7.
24. Luft D, Schmülling RM, Eggstein M. Lactic acidosis in biguanidetreated diabetics. A review of 330 cases. Diabetologia 1978;14:75-87.
25. Wen YK. Impact of acute kidney injury on metformin-associated lactic acidosis. Int Urol Nephrol 2009;41:967-72.
26. Nyirenda MJ, Sandeep T, Grant I, Price G, McKnight JA. Severe acidosis in patients taking metformin-rapid reversal and survival despite high APACHE score. Diabetes Med 2006;23:432-5.
27. Prikis M, Mesler EL, Hood VL, Weise WJ. When a friend can become an enemy! Recognition and management of metforminassociated lactic acidosis. Kidney Int 2007;72:1157-60.
28. Bruijstens LA, van Luin M, Buscher-Jungerhans PM, Bosch FH. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment. Neth J Med 2008; 66:185-90.
29. Friesecke S, Abel P, Roser M, Felix SB, Runge S. Outcome of severe lactic acidosis associated with metformin accumulation. Crit Care 2010;14:R226.
30. Biradar V, Moran JL, Peake SL, Peter JV. Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit. Crit Care Resusc 2010;12:191-5.
31. Scale T, Harvey JN. Diabetes, metformin and lactic acidosis. Clin Endocrinol (Oxf) 2011;74:191-6.
32. Arroyo D, Melero R, Panizo N, Goicoechea M, Rodríguez-Benítez P, Vinuesa SG, et al. Metformin-associated acute kidney injury and lactic acidosis. Int J Nephrol 2011;2011:749653.
33. Duong JK, Furlong TJ, Roberts DM, Graham GG, Greenfield JR, Williams KM, et al. The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf 2013;36:733-46.
34. Nguyen HL, Concepcion L. Metformin intoxication requiring dialysis. Hemodial Int 2011;15:S68-71.
35. Schwarzbeck A, Hastka J, Kühnle F, Rambausek M. Metforminassociated lactic acidosis in diabetic patients with acute renal failure. Nephrol Dial Transplant 1995;10:425-6.
36. Vecchio S, Giampreti A, Petrolini VM, Lonati D, Protti A, Papa P, et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol 2014;52:129-35.
37. Liang KV, Grande JP, Fidler ME, Garovic VD. La nefrite interstiziale acuta indotta dalla levofloxacina. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2012;171:227-31.